Guillain ‐Barré syndrome after COVID‐19 vaccine: A temporal association
ConclusionsThen, in the absence of other causes, the diagnosis of GBS was made, with evidence of a clear temporal association with COVID-19 vaccine. However a cautious position is important when assigning a particular side effect directly to a vaccine. It is important to emphasize that it is a temporal association only and the benefits of vaccination continue to outweigh the possible consequences.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Gustavo Figueiredo da Silva,
Caroline Figueiredo da Silva,
Raddib Eduardo Noleto da Nobrega Oliveira,
Fabiana Romancini,
Rafael Marques Mendes,
Amanda Locks,
Maria Francisca Moro Longo,
Carla Heloisa Cabral Moro,
Alexandre Luiz Longo,
Vera Lucia Tags: CASE REPORT Source Type: research
More News: AstraZeneca | Brain | COVID-19 | Cytology | Gastroenterology | Guillain-Barr Syndrome | Men | Neurology | Pandemics | Respiratory Medicine | SARS | Vaccines